Offshore Dermatology Billing 2026 Skin Biopsy, Mohs Surgery & Cosmetic vs. Medical Coding from India

Why Dermatology Practices Need Offshore Billing in 2026

Dermatology generates one of the most diverse claim mixes in medicine. A single day in a busy dermatology practice produces claims spanning routine E/M visits, skin biopsies with multiple techniques (shave, punch, excisional), destruction of premalignant and malignant lesions, Mohs micrographic surgery with multiple stages and blocks, cosmetic procedure documentation, biologic injection administration for psoriasis, and phototherapy sessions — each governed by distinct coding rules, bundling hierarchies, and payer-specific cosmetic exclusion policies.

In 2026, dermatology billing complexity has increased further. CMS refined the biopsy code definitions to clarify the distinction between shave removal and tangential biopsy, maintained strict NCCI bundling edits around destruction codes and E/M services, and increased scrutiny on the cosmetic vs. medical distinction for procedures like lesion removal, chemical peels, and laser therapy. Commercial payers have expanded step therapy requirements for biologic medications and tightened prior authorization criteria for Mohs surgery referrals.

A dedicated ICS offshore FTE at $8.5/hr per hour manages the full dermatology billing workflow — from biopsy code selection and Mohs stage counting to cosmetic vs. medical documentation compliance to biologic J-code administration billing. This guide covers the critical codes, payer rules, and documentation requirements your offshore team needs.

Skin Biopsy Billing: Shave, Punch & Excisional Techniques

Skin biopsy is the most frequently performed dermatologic procedure, and the coding structure distinguishes between three biopsy techniques — shave (tangential), punch (cylindrical), and excisional (full-thickness). Each technique has its own CPT code range, and the rules governing which codes can be billed together and how multiple biopsies on the same date are coded create significant billing complexity.

Skin Biopsy CPT Codes

Biopsy Billing Rules for 2026

One Primary + Add-Ons: For multiple biopsies on the same date, bill ONE primary code (11102, 11104, or 11106) and add-on codes (11103, 11105, or 11107) for each additional lesion. When different biopsy techniques are used on the same date (e.g., shave biopsy of one lesion + punch biopsy of another), bill the primary code for the first technique and add-on codes for all additional lesions regardless of technique.

Only One Primary Code Per Date: Do NOT bill 11102 + 11104 as two primary codes on the same date. Only one primary biopsy code is allowed per date of service. The additional lesions — even if biopsied with a different technique — are billed using the appropriate add-on code. This is the most common dermatology biopsy billing error.

Biopsy vs. Shave Removal: A tangential biopsy (11102) is performed for diagnostic purposes — to obtain a tissue specimen for pathologic examination. A shave removal (11300-11313) is performed for therapeutic purposes — to remove a lesion completely. If the intent is diagnostic (sending tissue to pathology), use the biopsy code. If the intent is therapeutic removal, use the shave removal code. Billing both for the same lesion is not appropriate.

Pathology Correlation: Your ICS FTE cross-references every biopsy claim against the pathology report to verify that the number of specimens submitted matches the number of biopsy sites billed. A claim for 11102 + 11103 x3 (four biopsy sites) with only two pathology specimens indicates a billing error that needs correction before submission.

Shave Removal vs. Excision Codes

Size Measurement Is Critical: Excision codes (11400-11446, 11600-11646) are size-based — the narrowest margin PLUS the lesion diameter determines the code. Documentation must include the measured diameter of the lesion and the narrowest margin in centimeters BEFORE excision. Post-excision specimen size reported by pathology often differs due to tissue shrinkage and does not determine the billing code.

Simple Closure Is Included: Simple (layered) closure is bundled into all excision codes. Only intermediate repair (12031-12057) and complex repair (13100-13160) are separately billable above the excision. Billing simple repair alongside an excision triggers NCCI edit denials.

Mohs Micrographic Surgery Billing

Mohs surgery is the highest-value procedure in dermatology and one of the most complex to bill correctly. The billing structure involves stage-based coding (first stage, each additional stage), tissue block counting per stage, and separate reconstruction coding — all on the same date of service. Errors in Mohs billing are among the most costly in dermatology.

Mohs Surgery CPT Codes

Mohs Billing Rules

Stage Counting: Each stage represents a complete cycle of tissue excision, mapping, histologic preparation, and microscopic examination. The first stage is billed as 17311 or 17313 (depending on anatomic site). Each subsequent stage is billed as 17312 or 17314. A typical Mohs case involves 1-3 stages. The operative report must document each stage separately with a tissue map, block count, and margin status.

Tissue Block Counting: Each stage code includes up to 5 tissue blocks. If a single stage requires more than 5 blocks (large or irregular tumors), bill 17315 for each additional block beyond 5. The pathology log must document the exact number of tissue blocks processed per stage.

Reconstruction Is Separately Billed: The wound repair/reconstruction after Mohs clearance is billed separately using the appropriate repair code (intermediate repair 12031-12057, complex repair 13100-13160, adjacent tissue transfer 14000-14302, or skin graft 15100-15278). Mohs codes cover only the tissue removal and histologic examination — not the closure.

Mohs + Reconstruction Modifiers: When the Mohs surgeon also performs the reconstruction on the same day, no special modifier is needed — the Mohs codes and repair codes are separately billable by the same physician. However, if a different surgeon performs the reconstruction, that surgeon bills the repair code with modifier -58 (staged procedure) or documentation of the referral arrangement.

Mohs Medical Necessity Requirements

Appropriate Tumor Types: Mohs surgery is indicated for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in high-risk locations (head, neck, hands, feet, genitalia), recurrent tumors, tumors with aggressive histologic subtypes (morpheaform BCC, poorly differentiated SCC), and tumors requiring maximal tissue conservation. Payers deny Mohs claims for low-risk tumors on the trunk or extremities that could be adequately treated with standard excision.

Prior Authorization: Many commercial payers and Medicare Advantage plans require prior authorization for Mohs surgery. The authorization request must include pathology confirmation of malignancy, tumor size and location, risk factors justifying Mohs over standard excision, and the estimated number of stages. Your ICS FTE manages PA submissions and tracks authorization status before the scheduled procedure.

Cosmetic vs. Medical Coding: The Critical Distinction

The cosmetic vs. medical coding distinction is the single highest-risk area in dermatology billing. Procedures performed for cosmetic purposes are not covered by any insurance plan, while the same procedure performed for medical indications is fully covered. The documentation — not the procedure itself — determines whether a claim is billable or constitutes fraud. Your ICS offshore FTE is trained to identify and flag cosmetic vs. medical coding issues before claims are submitted.

Common Dual-Purpose Procedures

Cosmetic vs. Medical Documentation Requirements

Medical Necessity Language: For every procedure that could be interpreted as cosmetic, the documentation must explicitly state the medical indication: symptoms (pain, bleeding, itching, irritation), clinical concern (atypical features, growth, color change), functional impairment (lesion catches on clothing, impairs vision, causes recurrent infection), or pathology results confirming disease. ‘Patient requests removal’ without medical justification is insufficient.

Cosmetic Waiver Required: When a procedure is performed for cosmetic purposes, the practice must have the patient sign a cosmetic waiver acknowledging that insurance will not cover the service and the patient is responsible for the full fee. Billing a cosmetic procedure to insurance — even with a medical diagnosis code attached — constitutes fraud.

Split Procedures: When a patient presents for both medical and cosmetic services in the same visit (e.g., biopsy of a suspicious mole + cosmetic removal of skin tags), the medical services are billed to insurance and the cosmetic services are billed directly to the patient. The documentation must clearly separate the medical and cosmetic components. Your ICS FTE reviews every claim for split-visit coding accuracy.

Destruction of Lesions: Premalignant vs. Benign

Premalignant Counting Rules: For premalignant lesions (actinic keratoses), bill 17000 for the first lesion and 17003 for each additional lesion from 2 through 14. When 15 or more premalignant lesions are treated on the same date, bill 17004 as a flat-rate code INSTEAD of 17000 + 17003. Do not bill 17000 + 17003 + 17004 together — 17004 replaces the other codes entirely.

Benign Destruction Is Flat Rate: CPT 17110 covers destruction of up to 14 benign lesions regardless of the number treated. Do not bill 17110 multiple times or per-lesion. For 15 or more benign lesions, bill 17111 instead. Your ICS FTE verifies the lesion count and applies the correct flat-rate code.

Biologic Administration and Phototherapy Billing

Biologic medications for psoriasis, atopic dermatitis, and other inflammatory skin conditions represent a rapidly growing revenue stream for dermatology practices that administer these drugs in-office. The billing involves drug J-codes, administration codes, and complex prior authorization workflows that demand precise tracking.

Common Dermatology Biologic and Drug Codes

Phototherapy Codes

Biologic J-Code Units: Biologic drugs are billed per milligram. A 90 mg dose of ustekinumab (J3357) requires 90 units on the claim. Incorrect unit reporting — billing ‘1’ instead of ’90’ — results in reimbursement of a fraction of the drug cost. Your ICS FTE cross-checks the medication administration record against the billed J-code units on every biologic claim.

Phototherapy Session Limits: Most payers authorize phototherapy in blocks of 24-36 sessions. Your FTE tracks session counts and initiates re-authorization requests before the authorized sessions are exhausted, preventing treatment gaps.

Essential ICD-10 Codes for Dermatology

The Offshore FTE Advantage for Dermatology Practices

Dermatology generates an exceptionally high claim volume relative to practice size — a single provider may perform 30-50 billable procedures per day across biopsies, destructions, excisions, Mohs stages, and E/M visits. The combination of high volume, multi-technique biopsy coding, cosmetic vs. medical gatekeeping, Mohs stage and block counting, and biologic prior authorization management creates a billing workload that overwhelms in-house teams.

Cost Comparison: In-House vs. ICS Offshore FTE

What Your ICS Dermatology FTE Handles Daily

• Biopsy code technique matching — selecting the correct primary code (11102 tangential, 11104 punch, or 11106 incisional) and preventing dual primary code billing on same-date multi-technique biopsies
• Mohs stage and tissue block reconciliation — counting stages from the operative report tissue map and adding 17315 for blocks exceeding five per stage
• Cosmetic vs. medical documentation audit — reviewing every dual-purpose procedure claim for explicit medical necessity language before submission
• Destruction lesion counting — verifying the premalignant lesion count and switching from 17000+17003 to 17004 flat rate at the 15-lesion threshold
• Biologic J-code unit verification — cross-checking administered dose against J-code milligram units to prevent underbilling on every biologic claim
• Excision size code selection — verifying measured lesion diameter plus narrowest margin against the correct size-based excision code range

Top 5 Dermatology Billing Denial Triggers and Offshore Prevention

1. Multiple Primary Biopsy Codes on Same Date

Billing 11102 (tangential) and 11104 (punch) as two primary codes on the same date is the most common dermatology biopsy billing error. Only ONE primary biopsy code is allowed per date of service; additional biopsies — regardless of technique — must use the corresponding add-on codes (11103, 11105, or 11107). Your ICS FTE applies the one-primary-code rule to every multi-biopsy claim before submission.

2. Mohs Stage Undercount or Block Miscount

Undercounting Mohs stages leaves revenue on the table; overcounting triggers audit flags. Each stage must be documented with its own tissue map, block count, and margin assessment in the operative report. Your FTE reconciles the stage count and block count from the operative report against the billed codes, adding 17315 units for extra blocks and ensuring every documented stage has a corresponding billing line.

3. Cosmetic Procedure Billed with Medical Diagnosis

Attaching a medical diagnosis code (e.g., L82.1 seborrheic keratosis) to a procedure performed for purely cosmetic reasons constitutes fraud. The documentation must support the medical indication with symptoms, clinical findings, or functional impairment. Your ICS FTE reviews every lesion removal and destruction claim for documented medical necessity, flagging claims where the notes indicate cosmetic motivation without medical justification.

4. Simple Closure Billed Separately from Excision

Simple closure (12001-12007) is inherent in all excision codes (11400-11446, 11600-11646). Billing a simple repair alongside an excision triggers automatic NCCI edit denials. Only intermediate (12031-12057) and complex (13100-13160) repairs are separately billable. Your FTE scrubs every excision claim to ensure simple closure is not billed as a separate line item.

5. Destruction Code 17004 Billed with 17000/17003

When 15 or more premalignant lesions are treated on the same date, CPT 17004 is the correct flat-rate code that REPLACES 17000 and 17003 entirely. Billing 17000 + 17003 + 17004 together triggers immediate denial. Your ICS FTE monitors the lesion count on every actinic keratosis destruction claim and applies the correct code structure — either 17000 + 17003 (for fewer than 15 lesions) or 17004 alone (for 15 or more).

Start with One Dedicated Dermatology Billing FTE

ICS provides HIPAA-compliant, CPC-certified offshore billing specialists with specific training in dermatology coding — including multi-technique biopsy billing, Mohs surgery stage management, cosmetic vs. medical compliance, destruction code thresholds, and biologic prior authorization tracking.

At $8.5/hr per hour all-inclusive, one FTE handles the billing volume that would require 2-3 part-time U.S. staff. Start with one FTE and scale as your practice grows.

FAQs – Offshore Dermatology Billing 2026

1. What is offshore dermatology billing?
Offshore dermatology billing is the process of outsourcing dermatology medical billing tasks, such as claim submission, coding, payment posting, and denial management, to specialized billing teams located outside the United States, including India.

2. How is skin biopsy coding handled in dermatology billing?
Skin biopsy coding depends on the biopsy method, the number of lesions treated, and the anatomical location. Accurate documentation and proper CPT and ICD-10 code selection are essential to ensure clean claim submission and reimbursement.

3. What makes Mohs surgery billing complex?
Mohs surgery billing involves coding multiple stages, tissue mapping, pathology evaluation, and reconstruction procedures when applicable. Proper coding is necessary to avoid claim denials and maximize reimbursement.

4. What is the difference between cosmetic and medical dermatology coding?
Medical dermatology procedures are performed to diagnose or treat a medical condition and are typically covered by insurance. Cosmetic procedures are performed primarily for aesthetic purposes and are generally not covered by insurance, requiring different billing and documentation practices.

5. Why do U.S. dermatology practices outsource billing to India?
Many dermatology practices choose offshore billing services in India to reduce operational costs, gain access to experienced medical coders, improve claim accuracy, and maintain consistent revenue cycle management.

Related Blogs

Maximizing Collections: Strategies an Offshore A/R Follow-Up Team Uses to Reduce Days in A/R

Have you ever questioned why some healthcare organizations manage to receive reimbursements quickly whereas others struggle with long payment delays? Read more

HIPAA Compliance Offshore: Vetting Your Partner for World-Class Data Security Protocols

Every year, hundreds of millions of medical records are exposed in security breaches, and the cost of a single breach Read more

RCM Outsourcing Trends 2025–2026: Why More Practices Are Choosing Offshore Billing Partners

Healthcare providers are entering a period where managing the revenue cycle feels more demanding than ever. Costs continue to rise, Read more